Zfp467-flox Mouse

Zfp467, also known as EZI, is a zinc-finger transcription factor. It plays a crucial role in the differentiation of mesenchymal progenitor cells, being involved in pathways related to osteogenesis and adipogenesis. It is also associated with the regulation of Wnt signaling, which is important for bone formation [3,4].

Genetic loss-of-function studies, especially in KO and CKO mouse models, have revealed significant insights. Conditional deletion of Zfp467 in osteogenic precursors led to high bone mass in mice, as Prrx1Cre; Zfp467fl/fl mice showed greater osteogenic differentiation similar to Zfp467-/-mice. Loss of Zfp467 increased Pth1r expression, enhancing the osteogenic response to PTH, and also led to higher nuclear translocation of NFκB1 that binds to the P2 promoter of the Pth1r and increases its transcription. In vitro, COBs and BMSCs from Zfp467-/-mice showed more positive ALP and Alizarin Red staining, decreased adipocyte-related markers, and increased Pth1r mRNA and protein levels [1,2].

In conclusion, Zfp467 negatively influences skeletal homeostasis by favoring adipogenesis over osteogenesis. The Zfp467 KO/CKO mouse models have provided valuable insights into its role in bone-related diseases, suggesting that its repression could be a component of PTH-based therapeutic strategies for osteoporosis and other bone-loss conditions [2].